首页> 外文会议>International conference on biomedical optics >Photomodification of sensitizers commonly used in photosensitized tumour therapy
【24h】

Photomodification of sensitizers commonly used in photosensitized tumour therapy

机译:常用于光敏肿瘤疗法的敏化剂的光掩髓

获取原文

摘要

Photostability studies of porphyrin-type sensitizers performed in aqueous solutions, model systems (sensitizers bound to human serum albumin or in a suspension of released erythrocyte ghosts) and in tumour tissue reveal that similar photomodification takes place in all investigated environments: photobleaching during exposure to light is followed by the formation of red-absorbing photoproducts. Photoproducts are not formed in the solutions of the less photostable sensitizer chlorin e_6 and the most photostable sensitizer aluminium phthalocyanine tetrasulphonate. Interaction with photooxidizible biomolecules increases the photobleaching rate of porphyrin-type sensitizers. This should be taken into account in the estimation of optimal photodynamic doses. The modified formula including photodestruction of sensitizer and formation of photoproduct is suggested.
机译:在水溶液中进行的卟啉型敏化剂的光稳定性研究,模型系统(结合人血清白蛋白或释放的红细胞鬼魂悬浮液中的敏化剂)和肿瘤组织揭示了所有调查环境中发生的相似的光浆液:在暴露于光线期间的光博然后形成红色吸收光调节。在较低的光稳定敏化剂氯庚烷E_6和最具光稳定的敏化剂铝酞菁四硫酸铝的溶液中不形成光调节。与光氧化的生物分子的相互作用增加了卟啉型敏化剂的光漂白率。应考虑到最佳光动力剂量的估计中。提出了包括敏化剂的光脱模的改性公式和光调节的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号